Clinical Trial Update: Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

A phase 4 trial comparing vildagliptin and glimepiride for glucose variability in patients with type 2 diabetes not adequately controlled on metformin was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2015-10-28